The American Journal of Infection Control is a leading peer-reviewed publication dedicated to advancing the field of infection prevention and control. Published by Mosby-Elsevier, this journal has been a crucial resource since its inception in 1980, focusing on the intersection of infectious diseases, public health, and health policy. As of 2023, it holds an impressive Q1 ranking in both Health Policy and Public Health, Environmental and Occupational Health, while also achieving Q2 rankings in Epidemiology and Infectious Diseases. With an increasing impact factor and a strong reputation reflected in its Scopus rankings, the journal appeals to researchers, health professionals, and students committed to preventing the spread of infections and enhancing healthcare safety. Although it does not currently offer Open Access, the journal ensures broad dissemination of its vital research through various subscription options. By fostering interdisciplinary collaboration and evidence-based practices, the American Journal of Infection Control plays a pivotal role in shaping effective infection control policies and practices worldwide.

Infection Disease & Health, published by Elsevier Inc, serves as a premier interdisciplinary journal dedicated to advancing the fields of infectious diseases, public health, and nursing. With an impressive impact factor reflective of its rigorous scholarly contributions, the journal is currently indexed within the Q2 category in Infectious Diseases and Q1 in Nursing (miscellaneous) as of 2023, indicating its esteemed position in these areas. Launched in 2016, it has rapidly established itself as a valuable resource for researchers, clinicians, and students alike, emphasizing both original research and comprehensive reviews that address pressing health challenges. Authors and readers are encouraged to engage with a wealth of content that is meticulously curated to inform and inspire innovative practices within the health sector. While the journal is not an open-access platform, it offers various access options to enhance dissemination of knowledge. As the field of infectious diseases evolves, Infection Disease & Health remains at the forefront, fostering scholarly dialogue and contributing to the development of effective health strategies globally.

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.

Tropical Medicine and Infectious Disease, published by MDPI, is a leading peer-reviewed journal dedicated to advancing the field of tropical medicine and infectious diseases. With an open access model established since 2016, this journal fosters a collaborative environment for researchers, professionals, and students from around the world to disseminate cutting-edge findings and innovative approaches to public health challenges, particularly in tropical regions. The journal has earned recognition, achieving a Q2 quartile ranking in notable fields including Immunology and Microbiology, Infectious Diseases, and Public Health, Environmental, and Occupational Health in 2023, indicative of its influence and relevance in the scientific community. With a focus on high-quality research, Tropical Medicine and Infectious Disease aims to bridge the gap between basic science and clinical application, providing invaluable insights critical for combating infectious diseases and improving health outcomes in vulnerable populations. The journal’s accessibility and substantial indexing in major databases further solidify its importance as a key platform for impactful research in this essential field.

Infection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

Revista de Epidemiologia e Controle de Infeccao, published by Universidade de Santa Cruz do Sul, stands as a vital resource for scholars and practitioners in the fields of epidemiology and infection control. This open-access journal, available since 2011, fosters the dissemination of high-quality research and practice-based knowledge aimed at enhancing public health and improving infection management strategies. With its commitment to sharing invaluable insights from Brazil and beyond, the journal encourages broader participation in critical discussions surrounding infectious diseases. Although specific metrics such as the HIndex and Scopus rankings are currently omitted, the journal's relevance is underscored by its open accessibility, allowing a global audience of researchers, healthcare professionals, and students to engage with innovative studies and findings in this essential area of public health.

Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.

Journal of Hospital Infection, published by W B SAUNDERS CO LTD, stands as a pivotal resource in the infectious diseases, medicine, and microbiology sectors. With an impressive impact factor positioning it in the Q1 quartile across its relevant categories, this journal not only ranks highly—#32 out of 344 in Infectious Diseases and #17 out of 140 in Medical Microbiology—but also exemplifies a commitment to advancing knowledge and practice in hospital infection control. Since its inception in 1980, the journal has become a vital platform for disseminating research that informs clinical practices, promotes safety in health care environments, and enhances medical education. While access is non-open, the journal's extensive scope and rigorously peer-reviewed contributions ensure its relevance and significance to researchers, professionals, and students aiming to stay at the forefront of this dynamic field. The journal’s headquarters in London underscores its international relevance, making it an essential reference for anyone involved in combating hospital-acquired infections.